AP-SA02

· Armata Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AP-SA02, covering 2026-03-23 to 2026-03-23. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia [Phase 1, Phase 2]

See pricing